News items related to: Call to action
-
World Health Day petition: No profit on pandemic!
Nine out of 10 people in low and middle income countries won’t have access to a COVID-19 vaccine in 2021....
-
Russian government advised – “issue compulsory license to make generic COVID-19 drug available”
First civil society, and now a generic drug company, have asked the Russian government to issue a compulsory license on...
-
HIV: Switch to generic darunavir in Kyrgyzstan and save $53,000
First published by the Partnership Network Association in Kyrgyzstan, read here in Russian. Analysis carried out by our campaign partner,...
-
Russian patient organizations ask Gilead to disclaim patents for Truvada
On 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...
-
USA-Kenya Trade Agreement: No IP barriers to affordable medicines
“Access to medicines is a fundamental element of the right to health” states our partner, the Kenya Legal and Ethical...
-
CPTPP: Global civil society writes to Thai Prime Minister warning access to treatment is at risk
Civil society groups and non-government organizations in Thailand have, since March 2020, been expressing their grave concerns over the adverse...
-
CSO Open Letter to Thailand’s Prime Minister
CSO Open Letter to Thailand’s Prime Minister and the Chairperson of the Special Committee on the Study of the CPTPP’s...
-
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Positive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
This week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Our partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
-
Civil society asks WHO and Unitaid to ensure equitable access to COVID-19 technologies – and that commitment is binding
In an open letter, sent to Unitaid, the World Health Organization (WHO) and its Member States today, 86 civil society...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...